Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials

Lancet Infect Dis. 2021 Oct;21(10):1345-1347. doi: 10.1016/S1473-3099(21)00464-3. Epub 2021 Aug 16.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Health Services Accessibility*
  • Humans

Substances

  • Antiviral Agents